- Home
- BLTE vs CAKE Comparison
BLTE vs CAKE Comparison
Compare BLTE & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- CAKE
- Stock Information
- Founded
- BLTE 2018
- CAKE 1972
- Country
- BLTE United States
- CAKE United States
- Employees
- BLTE N/A
- CAKE N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- CAKE Restaurants
- Sector
- BLTE Health Care
- CAKE Consumer Discretionary
- Exchange
- BLTE Nasdaq
- CAKE Nasdaq
- Market Cap
- BLTE 1.7B
- CAKE 2.0B
- IPO Year
- BLTE 2022
- CAKE 1992
- Fundamental
- Price
- BLTE $57.60
- CAKE $42.45
- Analyst Decision
- BLTE Strong Buy
- CAKE Hold
- Analyst Count
- BLTE 4
- CAKE 14
- Target Price
- BLTE $59.00
- CAKE $40.85
- AVG Volume (30 Days)
- BLTE 40.3K
- CAKE 935.1K
- Earning Date
- BLTE 11-12-2024
- CAKE 10-29-2024
- Dividend Yield
- BLTE N/A
- CAKE 2.54%
- EPS Growth
- BLTE N/A
- CAKE 82.87
- EPS
- BLTE N/A
- CAKE 2.39
- Revenue
- BLTE N/A
- CAKE $3,502,484,000.00
- Revenue This Year
- BLTE N/A
- CAKE $6.24
- Revenue Next Year
- BLTE N/A
- CAKE $5.72
- P/E Ratio
- BLTE N/A
- CAKE $17.73
- Revenue Growth
- BLTE N/A
- CAKE 2.74
- 52 Week Low
- BLTE $31.01
- CAKE $29.27
- 52 Week High
- BLTE $57.82
- CAKE $43.41
- Technical
- Relative Strength Index (RSI)
- BLTE 83.16
- CAKE 60.46
- Support Level
- BLTE $55.63
- CAKE $38.47
- Resistance Level
- BLTE $56.37
- CAKE $43.41
- Average True Range (ATR)
- BLTE 1.65
- CAKE 1.21
- MACD
- BLTE 0.53
- CAKE 0.20
- Stochastic Oscillator
- BLTE 97.94
- CAKE 80.84
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.